Solutions from PCC to IND Drug Development
One-stop solutions with integrated project management and execution, and accelerating the clinical trail initiation for competitive advantages. Once a PCC antibody is determined, it takes about 12 months to complete the preclinical R&D and IND filing. Sanyou has completed the PCC-to-IND development of several client’s projects which have been submitted for IND in both China and the U.S.
Service Highlights
1. Integrated PCC-to-IND services
With our integrated services, only antibody sequence information is required for the IND approval.
2. Over 30 ongoing PCC-to-IND projects
The disease spectrum includes hematologic malignancy, solid tumors, autoimmune disorders, eye diseases, metabolic disorders, infectious diseases, etc.
3. Experience of 5 IND projects
5 projects in the IND stage, with 1 application approved and 1 accepted.
4. IND delivery in 12 months
Integrated platforms enable 12-month delivery.
5. Various drug modalities
Various drug modalities such as monoclonal, bi-specific, trispecific antibodies and ADC.
6. Four sets of authorized host cells
Four sets of host cells supplied by Thermo Fisher, HORIZON, MERCK, and Quacells.
7. Antibody titer up to 12 g/L
Industry-leading antibody titer up to 12 g/L.
8. Antibody drug R&D team of 300 professionals
Team with extensive experience of project management and fast troubleshooting.
9. 100% successful deliveries
100% successful deliveries guaranteed by advanced platform technologies and extensive R&D experiences.
10. Flexible and customized business model
Flexible cooperation options oriented for successful project development.
Popular articles
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreAfter the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.
Learn more